Infectious Disease Diagnostics – Products

Oxford Nanopore and Cepheid to co-develop a rapid sequencing workflow for in-house infectious disease diagnostics.

FDA approves leading solution for latent tuberculosis diagnostics, advancing global effort to fight infectious diseases.

Thermo Fisher Scientific has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the Applied Biosystems™ TaqPath™ COVID-19, Flu A, Flu B, RSV Select Panel.

Thermo Fisher Scientific has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for the Applied BioSystems™ TaqPath™ COVID-19 Diagnostic PCR Kit.

Oxford Nanopore, announced a landmark strategic partnership with the UK Government. This partnership brings together the UK’s world-class scientific organisations Genomics England, UK Biobank and NHS England, alongside Oxford Nanopore.

Simplexa^® C. auris direct leverages the simplicity of the liaison^® MDX workflow, with minimal sample preparation and results in less than 2 hours with excellent clinical performance.

New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform. Substantially lowers hands-on time, allowing for increased lab productivity.

New and improved workflow now available that pairs Revvity’s T-SPOT™.TB test with the Auto-Pure 2400 liquid handling platform. Substantially lowers hands-on time, allowing for increased lab productivity.

At the ESCMID Global 2024 conference, Bruker is enhancing its innovative diagnostic solutions in microbial identification, antimicrobial susceptibility testing (AST), early sepsis diagnostics, and other infectious disease assays.

With its Vivalytic analysis platform, Bosch has set itself the goal of making fast and highly precise diagnostics accessible at the point of care. To achieve this, Bosch has now agreed on a strategic partnership with Randox Laboratories Ltd.